About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The broad purpose of the Epidemiology and Public Health research group is contributing to increase the available scientific evidence regarding preventive interventions, to promote health, and prevent morbidity and mortality from major diseases. Our group uses epidemiological methods to study etiology, surveillance, and efficacy of these interventions. We are primarily focused on epidemiology and prevention of infectious diseases, in both individual and population levels. Main lines of research:
IP: Juan Jose Gonzalez Lopez Collaborators: Manuel Hernández González, Jose Angel Rodrigo Pendás, Maria Belén Viñado Perez, Aina Aguiló Cucurull, Alba Mir Cros, Albert Moreno Mingorance, Andrea Martín Nalda, Nuria Serre Delcor, Josep Roca Grande, Laura Batlle Masó Funding agency: Instituto de Salud Carlos III Funding: 123420 Reference: PI21/00132 Duration: 01/01/2022 - 30/06/2026
IP: María Nieves Larrosa Escartin Collaborators: Jose Angel Rodrigo Pendás, Maria Belén Viñado Perez, Mª Carmen Ferrer Barberà, Nuria Fernández Hidalgo, Rosa Alcaraz Peñarrocha, Ma Dolores Rodríguez Pardo, Vanessa Casares Rodríguez, Albert Moreno Mingorance Funding agency: Instituto de Salud Carlos III Funding: 90750 Reference: PI21/01786 Duration: 01/01/2022 - 31/12/2024
PMID: 37695530 Journal: JOURNAL OF NEUROLOGY Year: 2023 Reference: J Neurol. 2023 Sep 11. doi: 10.1007/s00415-023-11973-y. Impact factor: Publication type: Paper in international publication Authors: Buti, Maria; Buti, Maria; Castillo, Joaquin; Marzo, Blanca; Montalban, Xavier; Otero-Romero, Susana; Otero-Romero, Susana; Riveiro-Barciela, Mar; Riveiro-Barciela, Mar; Robles-Sanchez, Miguel-Angel et al. DOI: 10.1007/s00415-023-11973-y
PMID: 37728389 Journal: Multiple Sclerosis Journal Year: 2023 Reference: Mult Scler. 2023 Sep 20:13524585231200303. doi: 10.1177/13524585231200303. Impact factor: Publication type: Paper in international publication Authors: Arrambide, Georgina; Bollo, Luca; Borras-Bemejo, Blanca; Braga, Nathane; Carbonell, Pere; Carvajal, Rene; Castillo, Joaquin; Cobo-Calvo, Alvaro; Cobo-Calvo, Alvaro; Comabella, Manuel et al. DOI: 10.1177/13524585231200303
PMID: 37766127 Journal: Vaccines Year: 2023 Reference: Vaccines (Basel). 2023 Sep 2;11(9):1450. doi: 10.3390/vaccines11091450. Impact factor: Publication type: Paper in international publication Authors: Andres, Cristina; Anton, Andres; Anton, Andres; Armadans-Gil, Lluis; Borras-Bermejo, Blanca; Borras-Bermejo, Blanca; Carbones-Fargas, Ingrid; Del Oso, Arnau; Fornaguera, Mar; Guananga, David et al. DOI: 10.3390/vaccines11091450
PMID: 37786980 Journal: Multiple Sclerosis Journal Year: 2023 Reference: Mult Scler. 2023 Oct 3:13524585231204126. doi: 10.1177/13524585231204126. Impact factor: Publication type: Editorail in international publication Authors: Otero-Romero, Susana; Otero-Romero, Susana; Reyes, Saul et al. DOI: 10.1177/13524585231204126
PMID: 34961900 Journal: Infectious Diseases and Therapy Year: 2022 Reference: Infect Dis Ther. 2022 Feb;11(1):463-483. doi: 10.1007/s40121-021-00571-y. Epub 2021 Dec 27. Impact factor: 5.322 Publication type: Paper in international publication Authors: Dos Santos, Gael; Wang, Hao; Jindal, Pooja; Rybo, Maria; Roul, Helene; Pallem, Sridevi; Eckermann, Tamara; Godderis, Lode; Martinez Gomez, Xavier; Godard, Eric et al. DOI: 10.1007/s40121-021-00571-y
PMID: 35740839 Journal: Children-Basel Year: 2022 Reference: Children (Basel). 2022 Jun 16;9(6). pii: children9060902. doi: 10.3390/children9060902. Impact factor: 2.863 Publication type: Paper in international publication Authors: Izurieta-Pacheco, Ana Carolina; Fresan-Ruiz, Elena; Girona-Alarcon, Monica; de Carlos-Vicente, Juan Carlos; Belda-Hofheinz, Sylvia; Nieto-Moro, Montserrat; Uriona-Tuma, Sonia Maria; Pinos-Tella, Laia; Morteruel-Arizcuren, Elvira; Schuffelmann, Cristina et al. DOI: 10.3390/children9060902
PMID: 35752569 Journal: ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA Year: 2022 Reference: Enferm Infecc Microbiol Clin (Engl Ed). 2022 Jun 22. pii: S2529-993X(22)00132-0. doi: 10.1016/j.eimce.2022.06.002. Impact factor: 1.731 Publication type: Paper in international publication Authors: Ruiz-Botia, Irene; Riera-Bosch, M Teresa; Rodriguez-Losada, Olalla; Soler-Palacin, Pere; Melendo, Susana; Moraga-Llop, Fernando; Balcells-Ramirez, Joan; Otero-Romero, Susana; Armadans-Gil, Lluis et al. DOI: 10.1016/j.eimce.2022.06.002
PMID: 35780057 Journal: Journal of healthcare quality research Year: 2022 Reference: J Healthc Qual Res. 2022 Mar 10. pii: S2603-6479(22)00012-4. doi: 10.1016/j.jhqr.2022.02.006. Impact factor: 0 Publication type: Paper in international publication Authors: Rodriguez, I; Barba, M-A; Cebrian, R; Abadias, M-J; Aller, M-B; Cossio-Gil, Y; Roman, A; Dominguez, J-M; Campins, M; Martinez, J et al. DOI: 10.1016/j.jhqr.2022.02.006
PMID: 32229130 Journal: ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA Year: 2021 Reference: Enferm Infecc Microbiol Clin. 2021 Mar;39(3):134-138. doi: 10.1016/j.eimc.2020.02.015. Epub 2020 Mar 27. Impact factor: 1.731 Publication type: Paper in national publication Authors: Melendo, Susana, Fernandez-Polo, Aurora, Castellnou Asens, Ivette, Mendoza-Palomar, Natalia, Barnes-Mayolas, Meritxell, Soler-Palacin, Pere, Soler Palacin, Pere, Melendo Perez, Susana, Mendoza Palomar, Natalia, Nieves Larrosa Escartin, M et al. DOI: 10.1016/j.eimc.2020.02.015
PMID: 30926297 Journal: VACCINE Year: 2019 Reference: Vaccine. 2019 Apr 24;37(18):2470-2476. doi: 10.1016/j.vaccine.2019.03.046. Epub 2019 Mar 27. Impact factor: 3.269 Publication type: Paper in international publication Authors: Andres, Cristina, Peremiquel-Trillas, Paula, Gimferrer, Laura, Pinana, Maria, Codina, Maria Gema, Rodrigo-Pendas, Jose Angel, Campins-Marti, Magda, Carmen Martin, Maria, Fuentes, Francisco, Rubio, Susana et al. DOI: 10.1016/j.vaccine.2019.03.046
PMID: 30860397 Journal: Future Microbiology Year: 2019 Reference: Future Microbiol. 2019 Mar;14:373-381. doi: 10.2217/fmb-2018-0261. Epub 2019 Mar 12. Impact factor: 2.746 Publication type: Paper in international publication Authors: Pinana, Maria, Andres, Cristina, Rodrigo-Pendas, Jose A, Peremiquel-Trillas, Paula, Codina, Maria G, Carmen Martin, Maria Del, Esperalba, Juliana, Fuentes, Francisco, Rubio, Susana, Campins-Marti, Magda et al. DOI: 10.2217/fmb-2018-0261
PMID: 30553564 Journal: ENVIRONMENT INTERNATIONAL Year: 2019 Reference: Environ Int. 2019 Jan;122:389-399. doi: 10.1016/j.envint.2018.12.007. Epub 2018 Dec 13. Impact factor: 7.943 Publication type: Paper in international publication Authors: Capelo, Rocio, Molina de la Torre, Antonio J, Salas Trejo, Dolores, Fernandez-Tardon, Guillermo, Lope, Virginia, Jimenez-Moleon, Jose J, Marcos-Gragera, Rafael, Dierssen-Sotos, Trinidad, Azpiri, Mikel, Munoz, Montse et al. DOI: 10.1016/j.envint.2018.12.007
On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.
This strategy protects almost two thirds of patients. It also reduces the waiting time between vaccination and initiation of immune suppressive treatment.
El VHIR va participar activament en l'assaig clínic d'aquesta vacuna que avaluava la seguretat, la tolerabilitat i l'eficàcia.
